BioSpace News Archive

Business

Vedanta Biosciences to Advance Cancer Immunotherapy Candidates Based on Microbiome-Derived Live Biotherapeutics that Induce CD8+ T Cells

Vedanta Biosciences announced that it has exclusively sub-licensed key intellectual property from JSR Corporation to develop and commercialize microbiome-derived cancer immunotherapies based on live biotherapeutics.

November 1, 2017

·

5 min read

Drug Development

Meta-Analysis Using Real-World Data Evaluates Safety Profile of Takeda’s Entyvio (vedolizumab) in Patients With Moderate to Severe Ulcerative Colitis or Crohn’s Disease

New meta-analysis provides a comprehensive view of real-world data and furthers understanding of Entyvio as an important treatment option for patients with ulcerative colitis or Crohn’s disease.

November 1, 2017

·

12 min read

Drug Development

TWi Biotech Presents Positive Results From AC-201 CR Phase II Proof-of-Concept Study in Gout Patients in 2017 ACR/ARPH Annual Meeting

The trial demonstrated taking 100mg AC-201CR twice a day in combination with 40mg febuxostat significantly increased the treatment success rate from 55% to 64% and from 27% to 39% defined as reaching serum uric acid concentration below 6mg/dL and 5mg/dL in 4 weeks, respectively.

November 1, 2017

·

5 min read

Business

Theravance Biopharma Announces Opening of Company’s New Corporate Office in Dublin, Ireland

Theravance today announced the opening of a new corporate office in Dublin, further establishing the Company’s presence in Ireland.

November 1, 2017

·

6 min read

Policy

Lannett Comments on Amended Civil Complaint

Lannett today responded to the allegations in the amended civil complaint by a number of states’ attorneys general pending in the U.S. District Court for the Eastern District of Pennsylvania against a number of sellers of generic pharmaceuticals involving a number of products.

November 1, 2017

·

2 min read

Business

Merrimack Announces Timing of Third Quarter 2017 Investor Conference Call

The call will cover an update on Merrimack’s recent progress as well as a summary of third quarter 2017 financial results.

November 1, 2017

·

2 min read

Business

Sigilon Therapeutics Appoints Eric Shaff to Board of Directors

Sigilon today announced the appointment of Eric Shaff, CFO of Seres, to the Sigilon board of directors.

November 1, 2017

·

2 min read

Business

Natera Chosen for Longitudinal Circulating Tumor DNA Study in Breast Cancer

Natera has entered into a research collaboration with Imperial College London and the University of Leicester, U.K., to leverage the company’s Signatera personalized ctDNA technology to evaluate retrospectively the use of ctDNA to detect disease recurrence in women breast cancer patients.

November 1, 2017

·

6 min read

Biotech Bay

Global Availability of Varian Halcyon Treatments Expands with First Cancer Patient Treated in Australia

Varian Medical Systems announced a 71-year-old male with prostate cancer became the first patient in Australia to be treated on the Halcyon system at ROC in Toowoomba by Brisbane-based Icon Group.

November 1, 2017

·

2 min read

BioMidwest

Baxter Launches PD-First Program for Employees and Families

Baxter announced a new PD-first program for its employees and family members aimed at improving education and awareness of dialysis treatment options, including peritoneal dialysis (PD).

November 1, 2017

·

3 min read